84-4998-19 MBNL2 (Muscleblind-Like Protein 1, Muscleblind-Like Splicing Regulator 1) 100ul 485522
特徴
- Mbnl2 mediates pre-mRNA alternative splicing regulation.
- It acts either as activator or repressor of splicing on specific pre-mRNA targets.
- It inhibits cardiac troponin-T (TNNT2) pre-mRNA exon inclusion but induces insulin receptor (IR) pre-mRNA exon inclusion in muscle.
- It antagonizes the alternative splicing activity pattern of CELF proteins.
- RNA-binding protein that binds to 5'ACACCC-3' core sequence, termed zipcode, within the 3'UTR of ITGA3.
- It binds to CUG triplet repeat expansion in myotonic dystrophy muscle cells by sequestering the target RNAs.
- It seems to regulate expression and localization of ITGA3 by transporting it from the nucleus to cytoplasm at adhesion plaques.
- It may play a role in myotonic dystrophy pathophysiology (DM).
- Applications:Suitable for use in Western Blot.
- Other applications not tested.
- Recommended Dilution:Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:100ul
- Host:rabbit
- Source Antibody:rat
- Grade:Affinity Purified
- Purity:Purified by affinity chromatography.
- Form:Supplied as a liquid in PBS, 2% sucrose, 0.09% sodium azide.
- Specificity:Recognizes rat MBNL2.
- Isotype:IgG
- Calc Applications Abbrev:WB
- Calc Crossreactivity:Rt
- Immunogen:Synthetic peptide corresponding to the middle region of RAT Mbnl2
- Shelf Life:1year
- Swiss Prot Number:F2Z3T4
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]